QurAlis
QurAlis is a clinical-stage biotechnology company that is developing precision medicines with genetically validated targets for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Its proprietary platforms and biomarkers allow for the design and development of drugs that target disease-causing genetic alterations directly.
Domain
quralis.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$88.0M
Founded
2016
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does QurAlis use?+
QurAlis uses 19 technologies including Google Tag Manager, WordPress, AccessiBe.
What industry is QurAlis in?+
QurAlis operates in the Biotechnology industry.
Where is QurAlis based?+
QurAlis is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026